<DOC>
	<DOCNO>NCT01456897</DOCNO>
	<brief_summary>To investigate safety efficacy long-term administration OPC-34712 patient schizophrenia .</brief_summary>
	<brief_title>A Long-term Trial OPC-34712 Patients With Schizophrenia</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<criteria>Patients age 18 year old ( time inform consent ) diagnose schizophrenia base DSMIVTR diagnostic criterion Outpatients receive oral antipsychotic treatment ( clozapine ) , consider require maintenance therapy use antipsychotic , monotherapy OPC34712 consider feasible Female patient breastfeed positive pregnancy test ( urine ) result prior receive investigational medicinal product Patients diagnosed disease schizophrenia ( schizoaffective disorder , major depressive disorder , bipolar disorder , posttraumatic stress disorder , anxiety disorder , delirium , dementia , amnesia , cognitive disorder ) base current DSMIVTR Axis Î™ criterion , diagnose personality disorder ( borderline , paranoid , histrionic , schizotypal , schizoid , antisocial )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>